08:41 AM EDT, 07/27/2026 (MT Newswires) -- Medicus Pharma ( MDCX ) said Monday that the US Food and Drug Administration issued a Study May Proceed letter for its Investigational New Drug application, allowing the company to begin an NDA-enabling Phase 2b SkinJect study in patients with Gorlin Syndrome. The SKNJCT-005 study will evaluate SkinJect 200 mcg in up to...

08:42 AM EDT, 07/27/2026 (MT Newswires) -- Argo (ARGH.V) raised C$10 million after closing a private placement with long-term institutional investors, the public transit solutions provider said Monday. Argo said it plans to use the proceeds to fund expansion plans in the US and Canada, fund research and development, and for working capital and general corporate purposes. Under the offering,...

Premier Marketing Agency Bolsters Conceptual Creative Capabilities by Acquiring Award-Winning Agency PLANO, Texas, July 27, 2026 /PRNewswire/ -- Today, RKD Group, North America's fundraising and marketing services firm supporting mission-driven organizations, announced its acquisition of Whiteboard. Founded in 1970, RKD Group serves over 250 enterprises across healthcare, disease research, social services, animal welfare, faith-based causes, education, humanitarian relief, and more....

LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...